JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

DaVita Inc

Closed

SectorHealthcare

141.27 5.61

Overview

Share price change

24h

Current

Min

133.76

Max

147.5

Key metrics

By Trading Economics

Income

34M

310M

Sales

41M

3.4B

P/E

Sector Avg

11.692

84.243

EPS

3.4

Profit margin

9.051

Employees

76,000

EBITDA

-53M

637M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+21.72% upside

Market Stats

By TradingEconomics

Market Cap

-1.3B

8B

Previous open

135.66

Previous close

141.27

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

DaVita Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 lut 2025, 19:50 UTC

Major Market Movers

DaVita Stock Declines After Outlook Miss, Berkshire Hathaway Sales

29 gru 2025, 06:30 UTC

Acquisitions, Mergers, Takeovers

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

21 mar 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Peer Comparison

Price change

DaVita Inc Forecast

Price Target

By TipRanks

21.72% upside

12 Months Forecast

Average 164 USD  21.72%

High 190 USD

Low 144 USD

Based on 5 Wall Street analysts offering 12 month price targets forDaVita Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

1

Buy

3

Hold

1

Sell

Technical Score

By Trading Central

142.36 / 144.275Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat